These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9875489)
1. Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model. Park KW; Yim CB; Kim KH Arch Pharm Res; 1998 Oct; 21(5):527-30. PubMed ID: 9875489 [TBL] [Abstract][Full Text] [Related]
2. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria. Nord CE J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398 [No Abstract] [Full Text] [Related]
3. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS; Tosin I; Sejas L; Miranda E Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842 [TBL] [Abstract][Full Text] [Related]
4. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections. Nomura S; Hanaki H; Nagayama A J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745 [TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria. Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257 [TBL] [Abstract][Full Text] [Related]
6. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors. Moosdeen F; Keeble J; Williams JD Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004 [TBL] [Abstract][Full Text] [Related]
8. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam. Piddock LJ; Jin YF; Turner HL J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105 [TBL] [Abstract][Full Text] [Related]
9. Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes. Cavalieri SJ; Sanders CC; New C Antimicrob Agents Chemother; 1991 Jul; 35(7):1343-7. PubMed ID: 1929291 [TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases. Danelon G; Mascaretti O; Radice M; Power P; Calcagno ML; Mata EG; Gutkind G J Antimicrob Chemother; 1998 Feb; 41(2):313-5. PubMed ID: 9533481 [No Abstract] [Full Text] [Related]
11. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases. Bonomo RA; Rudin SA; Shlaes DM FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111 [TBL] [Abstract][Full Text] [Related]
12. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam. Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864 [TBL] [Abstract][Full Text] [Related]
14. [Fundamental and clinical studies on beta-lactamase inhibitors]. Niki Y Nihon Rinsho; 2001 Apr; 59(4):771-6. PubMed ID: 11305004 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases. Gatermann S; Marre R Infection; 1991; 19(2):106-9. PubMed ID: 1646771 [TBL] [Abstract][Full Text] [Related]
16. Penicillins and beta-lactamase inhibitor combinations. Mealey KL J Am Vet Med Assoc; 2001 Jun; 218(12):1893-6. PubMed ID: 11417732 [TBL] [Abstract][Full Text] [Related]
17. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents. Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC Microbios; 1993; 76(309):251-61. PubMed ID: 8302203 [TBL] [Abstract][Full Text] [Related]
18. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms. Bolivar R; Weaver SS; Bodey GP Diagn Microbiol Infect Dis; 1984 Jun; 2(3):255-60. PubMed ID: 6086213 [TBL] [Abstract][Full Text] [Related]
19. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. Chin NX; McElrath MJ; Neu HC Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139 [TBL] [Abstract][Full Text] [Related]